Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation

Digestive Diseases

Volumn 25, Issue 4, 2007, Pages 303-309

  Takahashi, Shunsuke ^a   Kudo, Masatoshi ^a   Chung, Hobyung ^a   Inoue, Tatsuo ^a   Nagashima, Miki ^a   Kitai, Satoshi ^a   Tatsumi, Chie ^a   Minami, Yasunori ^a   Ueshima, Kazuomi ^a   Fukunaga, Toyokazu ^a   Haji, Seiji ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Liver resection; Liver transplantation; Milan criteria; Radiofrequency ablation

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; PEGINTERFERON ALPHA2A;

ADULT; AGED; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COHORT ANALYSIS; CONFERENCE PAPER; EARLY CANCER; FEMALE; HUMAN; IMMUNOTHERAPY; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER RESECTION; LIVER TRANSPLANTATION; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 35548980483     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106909     Document Type: Conference Paper

References (19)

1. Llovet JM, Fuster J, Bruix J: Intention-to-treat analysis of surgical therapy for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-1440.
2. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M: Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,000 cases. Cancer 2005;103:1201-1209.
3. Poon RT, Fan ST, Lo CM, Liu CL, Wong J: Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function. Ann Surg 2002;235:373-382.
4. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, Schiavo M, Garbagnati F, Marichiano A, Spreafico C, Camerini T, Mariani L, Miceli R, Andreola S: Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004;240:900-909.
5. Sakaguchi Y, Kudo M, Fukunaga T, Minami Y, Chung H, Kawasaki T: Low-dose, long-term, intermittent interferon-alpha-2b therapy after radical therapy by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma. Intervirology 2005;48:64-70.
6. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C: Small hepatocellular carcinoma in cirrhosis: randomized controlled trial of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-240.
7. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma of 4 cm or less. Gastroenterology 2004;127:1714-1723.
8. Choti MA: Surgical management of hepatocellular carcinoma: resection and ablation. J Vasc Interv Radiol 2002;13:S197-S203.
9. Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT: Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl 2004;10:1343-1354.
10. Zavaglia C, Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G: Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005;100:2708-2716.
11. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP: Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002;8:873-883.
12. Todo S, Furukawa H; Japanese Study Group on Organ Transplantation: Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004;240:451-461.
13. Trotter JF, Wachs M, Everson GT, Kam I: Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346:1074-1082.
14. Strong RW: Whither living donor liver transplantation? Liver Transpl Surg 1999;5:536-538.
15. Umeshita K, Fujiwara K, Kiyosawa K, Makuuchi M, Satomi S, Sugimachi K, Tanaka K, Monden M, Japanese Liver Transplantation Society: Operative morbidity of living liver donors in Japan. Lancet 2003;362:687-690.
16. Sun HC, Tang ZY: Preventive therapies for recurrence after curative therapies for recurrence after curative resection of hepatocellular carcinoma: a literature review of randomized control trials. World J Gastroenterol 2003;9:635-640.
17. Lin SM, Lin CJ, Hsu CW, Tai DI, Sheen IS, Lin DY, Liaw YF: Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors. Cancer 2004;100:376-382.
18. Nishiguchi S, Kuroki T, Nakatani S, Shiomi S, Seki S, Kobayashi K, Otani S: Randomized trial of effects of interferon-alpha on incidences of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-1055.
19. Shindo M, Ken A, Okuno T: Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy. Cancer 1999;85:1943-1950.